TheEdgeResearch
Home / Stocks / CENBF

CEN Biotech, Inc. (CENBF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$6,526
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-4.98
52-Wk Range
0.00001-0.0002
CEO
Brian S. Payne
Country
CA
Currency
USD

CEN Biotech, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Windsor, ON, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $6,526. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -153.5%. Its beta of -4.98 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.01
Price / Book
-0.00
EV / EBITDA
-6.66
Gross margin
50.5%
Operating margin
-128.2%
Net margin
-153.5%
Return on equity
Debt / equity
-2.28
Current ratio
0.03
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
4
IPO date
2020-05-04
Headquarters
Windsor, ON, CA
About CEN Biotech, Inc.

CEN Biotech, Inc. specializes in the creation, production, and ongoing development of both LED lighting technology and goods made from hemp. The company's future plans include cultivating hemp for use across various sectors, including industrial, medical, and food applications. Furthermore, it provides services in the areas of digital marketing and website development. The firm was founded in 2013 and has its headquarters in Windsor, Canada.

Comparable companies

CEN Biotech, Inc. is most often compared with the following Healthcare names:

BLMSDNAGMJNESAGDSESISPLMUPPRVIVXFWOWUWUHN
More research on CENBF
CENBF technical analysis CENBF TheEdge Score Compare against peers
Open full interactive analysis & DCF →